lomustine has been researched along with tretinoin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Baker, H | 1 |
Costello, C; McCarthy, D; Mir, N; Nadir, F; Rule, S; Samson, D; Taylor, J | 1 |
Arnold, H; Drings, P; Germano, G; Müller, KM; Obrecht, JP; Queisser, W; Weber, W; Westerhausen, M | 1 |
Obrecht, JP; Weber, W | 1 |
2 review(s) available for lomustine and tretinoin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Psoriasis: a review. II.
Topics: Adrenal Cortex Hormones; Anthralin; Azathioprine; Azauridine; Fluorouracil; Humans; Hydroxyurea; Lomustine; Mechlorethamine; Methotrexate; Psoriasis; Tars; Tretinoin; Ultraviolet Therapy | 1975 |
1 trial(s) available for lomustine and tretinoin
Article | Year |
---|---|
[Etretinate (Ro 10-9359, Tigason) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea) and bleomycin versus CCNU and bleomycin in the treatment of advanced squamous cell carcinoma of the bronchus (Working group on Internal Medicine Oncology Study BS1/7
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Drug Therapy, Combination; Etretinate; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Prognosis; Tretinoin | 1983 |
4 other study(ies) available for lomustine and tretinoin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Response to trans-retinoic acid in an AMLM3 patient resistant to cis-retinoic acid.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Lomustine; Male; Middle Aged; Stereoisomerism; Tretinoin | 1991 |
Etretinate, lomustine, and bleomycin versus lomustine and bleomycin in advanced squamous cell lung carcinoma.
Topics: Adult; Aged; Bleomycin; Drug Therapy, Combination; Etretinate; Female; Hematopoietic Stem Cells; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Tretinoin | 1983 |